Company intelligence / Profile preview

Camber Spine

King of Prussia, Pennsylvania, United Statescambermedtech.com ↗

Ownership: Private
Development stage: Commercial

Overview

Camber Spine has over 40 commercialized products for spinal surgery—including more than thirty with FDA 510(k) clearance—and holds over eighty global patents. Its ENZA®, SPIRA®, and OLIF systems are widely used in minimally invasive spinal fusion procedures. The company recently expanded into cellular allograft biologics with Scylla™, an allogeneic bone matrix containing viable cells for enhanced osteogenesis. Clinical results are not detailed publicly but the company’s products have received multiple industry awards and broad adoption among surgeons.

Therapeutic areas: OtherRheumatologyNeurology
Modalities: DeviceBiologic
Industry: Surgical Medical Devices

Partnerships

Private label agreement with a leading biologics company for Scylla™ cellular allograft product

Beyond the preview

Go deeper on Camber Spine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Camber Spine.

Explore the full profile